Heranba Industries Limited (NSE:HERANBA)
India · Delayed Price · Currency is INR | Market Cap | 15.62B |
| Revenue (ttm) | 14.10B |
| Net Income (ttm) | 30.70M |
| Shares Out | 40.01M |
| EPS (ttm) | 0.77 |
| PE Ratio | 508.84 |
| Forward PE | n/a |
| Dividend | 1.00 (0.26%) |
| Ex-Dividend Date | Sep 5, 2024 |
| Volume | 35,821 |
| Average Volume | 201,493 |
| Open | 391.95 |
| Previous Close | 390.40 |
| Day's Range | 381.00 - 393.90 |
| 52-Week Range | 208.00 - 562.00 |
| Beta | 0.19 |
| RSI | 65.60 |
| Earnings Date | Aug 12, 2025 |
About Heranba Industries
Heranba Industries Limited engages in the manufacture and sale of various agrochemicals in India. It offers intermediates, such as cypermethric acid chloride, high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha cypermethrin, tolfenpyrad, lambda cyhalothrin, permethrin, profenophos, dinotefuran, temephos, theta cypermethrin, diflubenzuron, ethion, methamidophos, thiophanate-methyl, bifenthrin, and propiconazole. The com... [Read more]
Financial Performance
In 2024, Heranba Industries's revenue was 14.10 billion, an increase of 12.14% compared to the previous year's 12.57 billion. Earnings were 30.70 million, a decrease of -91.20%.
Financial StatementsNews
Heranba Industries subsidiary begins commercial production at Sarigam Unit, Phase-II
Heranba Industries has announced that its wholly owned subsidiary, Heranba Organics Private Limited (HOPL), has officially started commercial production at its Sarigam Unit Phase-II, located in GIDC, ...